The Safety, Tolerability, and Efficacy of Once-Daily Memantine (28 mg): A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients with Moderate-to-Severe Alzheimer’s Disease Taking Cholinesterase Inhibitors

被引：0

作者：

George T. Grossberg

Facundo Manes

Ricardo F. Allegri

Luis Miguel Gutiérrez-Robledo

Sergio Gloger

Lei Xie

X. Daniel Jia

Vojislav Pejović

Michael L. Miller

James L. Perhach

Stephen M. Graham

机构：

[1] Saint Louis University School of Medicine,Department of Neurology and Psychiatry

[2] Instituto de Neurología Cognitiva (INECO),undefined

[3] Instituto de Investigaciones Neurológicas Raúl Carrea (FLENI),undefined

[4] Instituto de Geriatría,undefined

[5] Institutos Nacionales de Salud de México,undefined

[6] PsicoMedica Clinical and Research Group,undefined

[7] Forest Research Institute,undefined

[8] Prescott Medical Communications Group,undefined

来源：

CNS Drugs | 2013年 / 27卷

关键词：

Memantine; Cholinesterase Inhibitor; Semantic Fluency; Verbal Fluency Test; Severe Impairment Battery;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：469 / 478

页数：9